Health CareHealth Care Equipment & Services
  • Price (DKK)793.40
  • Today's Change-10.20 / -1.27%
  • Shares traded163.66k
  • 1 Year change27.39%
  • Beta1.0168
Data delayed at least 15 minutes, as of Dec 06 2019 15:59 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The Company supplies products to hospitals, institutions as well as wholesalers and pharmacies.

  • Revenue in DKK (TTM)17.94bn
  • Net income in DKK3.87bn
  • Incorporated1957
  • Employees12.07k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
ConvaTec Group PLC12.14bn1.09bn33.85bn9.50k30.773.1313.922.790.06250.06250.69560.61410.47832.906.53144,053.704.29-0.38144.80-0.416652.9352.908.97-0.84091.663.590.4985--3.831.5013.8565.1312.62--
Amplifon SpA12.14bn780.53m44.32bn10.77k56.699.3322.033.650.46220.46227.202.810.736921.7510.20150,878.204.745.036.466.6221.2356.616.446.290.570717.380.68825.347.6010.49-0.134250.8718.6426.63
GN Store Nord A/S12.08bn1.34bn44.91bn6.30k31.408.7219.033.7210.0510.0590.5636.210.88534.635.422,004,481.009.988.7713.7210.9761.1262.0611.2711.370.66915.180.548917.4210.669.3310.6111.045.549.95
Demant A/S14.51bn1.70bn51.51bn15.04k30.466.7521.443.556.896.8959.0431.090.7641.964.871,018,246.008.9710.9316.1617.9477.9875.4511.7413.220.502825.530.54770.005.679.243.937.241.21--
Sonova Holding AG19.69bn4.22bn97.66bn14.99k23.226.3218.134.969.579.5744.5835.190.663.146.75195,806.3014.3011.3218.4914.0171.2569.2521.6616.270.722473.050.229841.084.437.2113.495.914.498.83
Sartorius Stedim Biotech SA9.98bn1.78bn100.76bn5.95k56.4812.2744.0810.102.592.5914.5411.920.83522.585.63236,961.5014.9712.4720.3316.5951.5950.8917.9314.710.776624.450.133725.8512.1315.5529.1525.7143.2423.30
Straumann Holding AG9.97bn1.97bn103.08bn6.68k52.3012.1141.6110.3318.2018.2092.0878.560.7421.884.41245,572.0014.7915.8318.4618.3375.3376.7219.9320.791.0414.600.283434.1222.6114.93-2.4221.9354.056.96
Smith & Nephew plc33.39bn4.71bn130.20bn16.00k27.673.9016.743.900.6060.6064.304.300.59420.89673.98229,717.408.388.6210.0210.4773.8774.2114.1013.380.961315.190.305645.332.922.42-17.023.580.40845.19
Coloplast A/S17.94bn3.87bn157.09bn12.07k43.6524.3834.728.7618.1818.1884.1932.541.463.165.951,485,755.0031.6227.2052.1647.2267.7567.9621.5919.820.895649.550.1488100.879.067.620.728210.145.308.13
Koninklijke Philips NV142.78bn10.12bn288.20bn79.61k29.19--,899.20--2.44--3.5646.3443.807.133.81--18.74--114.411.92-3.8060.074.79-0.32891.22
Siemens Healthineers AG108.47bn11.71bn320.86bn52.00k27.484.3919.462.961.561.5614.499.780.7054.484.37279,192.307.70--10.49--39.92--10.92--1.0229.050.0159--8.11--23.87------
EssilorLuxottica SA112.12bn9.20bn453.26bn150.62k43.051.8022.564.043.223.2242.5577.250.4953.536.7699,630.854.456.615.438.7161.1560.759.0012.350.733720.520.155740.8517.5816.354.5212.8819.0416.76
Data as of Dec 06 2019. Currency figures normalised to Coloplast A/S's reporting currency: Danish Krone DKK

Institutional shareholders

11.35%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Oct 20193.80m1.92%
Capital Research & Management Co. (World Investors)as of 30 Sep 20193.70m1.87%
Norges Bank Investment Managementas of 31 Dec 20182.50m1.26%
Allianz Global Investors GmbHas of 28 Nov 20192.47m1.25%
Fundsmith LLPas of 30 Jun 20182.13m1.07%
Comgest SAas of 31 Jul 20192.06m1.04%
BlackRock Fund Advisorsas of 07 Nov 20191.88m0.95%
Capital Research & Management Co. (Global Investors)as of 30 Sep 20191.46m0.74%
Jupiter Asset Management Ltd.as of 30 Aug 20191.44m0.73%
Walter Scott & Partners Ltd.as of 30 Sep 20191.04m0.53%
More ▼
Data from 31 Dec 2018 - 30 Sep 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.